Patent · US Active

Specific binding molecules

US12371484B2 · kind B2 · utility

0Cited by
4References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2024
Grant dateJul 29, 2025
Priority date
Expiry dateFeb 13, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the formation of multi-domain specific binding molecules comprising VNARs. Specific binding domains that bind to Tumour Necrosis Factor alpha (TNFα) are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.